King Pharmaceuticals KG Unpaid losses and loss expenses
Unpaid losses and loss expenses at other companies
Other financials
Where this comes from
Reported directly by King Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve.
The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about King Pharmaceuticals's unpaid losses and loss expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is King Pharmaceuticals's unpaid losses and loss expenses?
- King Pharmaceuticals (KG) reported unpaid losses and loss expenses of -$16.74M in Q1 2026.